ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be "World's Lightest"

Nov.12.2024
ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be "World's Lightest"
ISMOD launches new HTP products in the US market, available on brand's website and vapesourcing, catering to e-cigarette users.

Special Disclaimer:

  • This article is for industry communication purposes only and does not endorse any brand or product.
  • The images displayed in this article are for factual description only and are not advertisements for any product.
  • This article is restricted to minors.

 

Recently, 2Firsts noticed that the heated tobacco brand ISMOD has launched two new HTP products in the US market—the ISMOD Mini Tobacco Heating Device and the ISMOD Jet Tobacco Heating Device. These products are now available on the ISMOD official website and the US e-cigarette distributor site, Vapesourcing.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
ISMOD Mini | Image source: ISMOD official website

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
ISMOD Jet | Image source: ISMOD official website

 

 Specifically, the product features of the ISMOD Mini and ISMOD Jet are as follows:

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Product specifications of ISMOD Mini and ISMOD Jet | Illustration: 2Firsts

 

According to the distributor website Vapesourcing, the ISMOD Mini is described as the "lightest HNB device in the world."

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
ISMOD Mini is the "lightest HNB device in the world" | Image source: vapesourcing

 

In addition, both the ISMOD Mini and ISMOD Jet are marked as "best used with BUDDZ tobacco sticks." The BUDDZ official website also features a heated tobacco device, the BUDDZ DEVICE, which closely resembles the ISMOD Mini in terms of design and specifications.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Translation: BUDDZ DEVICE | Image source: BUDDZ official website

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Translation into English: BUDDZ DEVICE|Image source: BUDDZ official website.

 

As early as the tobacco exhibition held in Dortmund this September, 2Firsts had already noticed the ISMOD brand and its products. The ISMOD II PLUS, in particular, became the brand's main highlight at the exhibition, featuring a battery device combined with two tobacco stick heating devices.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Translation: Dortmund Tobacco Exhibition ISMOD Booth | Image Source: 2Firsts

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
ISMOD II PLUS | Image Source: ISMOD

 

It is worth noting that the ISMOD Mini and ISMOD Jet were previously only available on the official ISMOD websites for regions such as Europe, the UK, and Jordan. Their launch on the US e-cigarette distributor site Vapesourcing makes them the only two HTP products currently listed on the site.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Heating tobacco devices displayed on the vapesourcing website | Image source: vapesourcing

 

The ISMOD official website shows that the brand is owned by ISMOD UK Ltd., a registered company in England and Wales with registration number 13047166. The company's registered address is in the Westminster district of the UK, and its business address is on Greenlands Avenue in London.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Company information displayed on the ISMOD brand official website | Image source: ISMOD official website

 

2Firsts will continue to monitor the latest products and market trends in the heated tobacco sector, providing the public with accurate and authoritative industry information.

 


 

2Firsts' product column remains committed to delivering readers the latest product updates in the new tobacco field. We invite readers to submit insights and news on e-cigarette developments.

 

For unique perspectives or information, feel free to contact us at carrie.cai@2firsts.com or scan the QR code below.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
DOJO officially launched the BLAST7K Fresh on September 17, 2026, introducing a UK-market prefilled pod product with 6ml of e-liquid and a manufacturer-rated capacity of up to 7,000 puffs. The device features a 1000mAh rechargeable battery, the INSTA-JUICED structure and COREX BLAST dual-mesh technology, while retaining compatibility with existing BLAST pods. The launch comes less than two weeks before the UK's Vaping Products Duty takes effect on October 1. At the new duty rate, 6ml of vaping liquid would correspond to £1.32 in VPD. DOJO has not stated that the product's 6ml format was designed in response to the new duty.
Sep.20
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Documents obtained by 2Firsts show that Sweden's Public Health Agency ordered Swedish Match to revise ingredient labels beyond the five ZYN products inspected. The dispute centers on whether flavoring ingredients must be individually disclosed, with Swedish Match citing trade-secret protection and the regulator insisting on full ingredient disclosure. The company faces a conditional penalty of SEK 2 million per month for noncompliance. As of October 22, the agency had received no appeal, despite the company's stated intention to challenge the decision.
Oct.22
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana's Alcohol and Tobacco Commission (ATC) ordered tobacco certificate holders in September to remove certain vaping products marketed under Elf Bar, Lost Mary, MR FOG, iJOY and other brands from inventory under the state's foreign-adversary product law. The agency later listed 257 MR FOG products and 77 Lost Mary product entries as lawful for sale. The Lost Mary revision expressly stated that compliance evidence had been received for 20 additional products. 2Firsts compliance expert Kurt said potential filings could include e-liquid and ingredient-origin records, U.S. nicotine-analog supply-chain documentation and FDA premarket application status.
Regulations
Oct.08
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Gallery | InterTabac 2026 Opens as VAPORESSO, SKE, GREENTANK, GEEK BAR and Other Brands Take the Floor
Gallery | InterTabac 2026 Opens as VAPORESSO, SKE, GREENTANK, GEEK BAR and Other Brands Take the Floor
InterTabac 2026 opened in Dortmund, Germany, on September 15 alongside NUBIZ and InterSupply. According to the latest figures released by the organizer, the three trade shows bring together around 750 exhibitors from 64 countries. On site, 2Firsts observed vaping and related brands including VAPORESSO, DOJO, SKE, GREENTANK, GEEK BAR, HQD and ELUX.
Special Report
Sep.15
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23